This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Eli Lilly & Co. jumped 14.3% to $839.96 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.1% to 5,282.70 and the Dow Jones Industrial Average falling 1.3% to 39,142.23.
Eli Lilly & Co. closed 13.6% below its 52-week high of $972.53, which the company achieved on August 22nd.
The stock outperformed some of its competitors, as Johnson & Johnson rose 2.3% to $157.47, Pfizer Inc. rose 0.5% to $22.14, and AbbVie Inc. rose 0.76% to $172.99.
Trading volume totaled 10.8 million, compared to the 50-day average of 3.7 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 17, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。